Washington, November 17 (RHC)-- U.S. President Donald Trump has nominated Alex Azar, a former top executive of pharmaceutical giant Eli Lilly, to lead the Department of Health and Human Services. The post has been vacant since the resignation of Tom Price.
Public Citizen’s Robert Weissman criticized the nomination, saying: “Tom Price supported Big Pharma in the U.S. Congress. Now apparently Trump has decided to cut out the middleman and let a pharmaceutical executive literally run the federal department that protects the health of all Americans.”
Donald Trump Nominates Former Drug Company Executive as HHS Secretary
Related Articles
Commentaries
MAKE A COMMENT
All fields requiredMore Views
- UN special rapporteur warns Israel's crimes in Gaza could keep International Court of Justice busy at The Hague for 50 years
- Arab countries at United Nations declare full support for new UN Security Council resolution that calls for permanent ceasefire in Gaza
- Israeli forces raped, tortured and executed Palestinian women at Al-Shifa Hospital
- Analysts say UK court ruling opens way for Julian Assange to be extradited to the United States soon
- International Labor Organization says profits from forced labor at nearly one-quarter of a trillion dollars